| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |